These fascinating science facts prove that reality is often stranger—and a lot more interesting—than fiction These ...
Phase 2a proof-of concept clinical trial for Cholesterol Efflux Mediator VAR 200 in patients with diabetic kidney disease (DKD) expected to begin H1-2025. Regulatory path for VAR 200's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback